论文部分内容阅读
前列腺癌是男性泌尿系统常见的恶性肿瘤之一,有统计数据[1]表明,2011年美国的前列腺癌发病率为第1位,死亡率为第2位。我国前列腺癌发病率虽明显低于欧美发达国家,随着我国老年化的进展,前列腺癌发病率在我国逐年上升[2]。目前,前列腺癌的治疗主要有前列腺根治术、放射治疗、内分泌治疗和化学治疗。有研究[3]表明,放射治疗可获得和手术相当生存率。且手术后并发症较
Prostate cancer is one of the common malignant tumors in male urinary system. Statistics [1] show that the incidence of prostate cancer in the United States in 2011 was No. 1 and the death rate was No. 2. Although the incidence of prostate cancer in our country is significantly lower than that in developed countries in Europe and the United States, with the progress of aging in our country, the incidence of prostate cancer is increasing year by year in our country [2]. Currently, the treatment of prostate cancer mainly prostatectomy, radiation therapy, endocrine therapy and chemotherapy. Some studies [3] showed that radiation therapy and surgical survival rate comparable. And complications after surgery